Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dysregulation of Hematopoiesis in Fanconi Anemia

NCT00900055 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT00900055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00900055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dysregulation of Hematopoiesis in Fanconi Anemia
Lead sponsor
OHSU Knight Cancer Institute
Phase
Observational
Overall status
Completed
Start date
June 30, 1975
Completion date
August 23, 2016
Enrollment
213 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative disorders, fanconi anemia, multiple myeloma and plasma cell neoplasm, myelodysplastic/myeloproliferative neoplasms